+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Prosthetic Devices - Medical Devices Pipeline Assessment, 2019

  • PDF Icon

    Report

  • 290 Pages
  • December 2019
  • Region: Global
  • GlobalData
  • ID: 4898175
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
Cardiovascular Prosthetic Devices - Medical Devices Pipeline Assessment, 2019

Summary

The Medical Devices sector report, “Cardiovascular Prosthetic Devices - Medical Devices Pipeline Assessment, 2019“ provides an overview of Cardiovascular Prosthetic Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiovascular Prosthetic Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by the team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Cardiovascular Prosthetic Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiovascular Prosthetic Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiovascular Prosthetic Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Introduction
1.1 Cardiovascular Prosthetic Devices Overview
2 Products under Development
2.1 Cardiovascular Prosthetic Devices - Pipeline Products by Stage of Development
2.2 Cardiovascular Prosthetic Devices - Pipeline Products by Segment
2.3 Cardiovascular Prosthetic Devices - Pipeline Products by Territory
2.4 Cardiovascular Prosthetic Devices - Pipeline Products by Regulatory Path
2.5 Cardiovascular Prosthetic Devices - Pipeline Products by Estimated Approval Date
2.6 Cardiovascular Prosthetic Devices - Ongoing Clinical Trials
3 Cardiovascular Prosthetic Devices - Pipeline Products under Development by Companies
3.1 Cardiovascular Prosthetic Devices Companies - Pipeline Products by Stage of Development
3.2 Cardiovascular Prosthetic Devices - Pipeline Products by Stage of Development
4 Cardiovascular Prosthetic Devices Companies and Product Overview
4.1 4Tech Cardio Ireland Ltd Company Overview
4.1.1 4Tech Cardio Ireland Ltd Pipeline Products & Ongoing Clinical Trials Overview
4.2 Abbott Vascular Inc Company Overview
4.2.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
4.3 Affluent Medical SA Company Overview
4.3.1 Affluent Medical SA Pipeline Products & Ongoing Clinical Trials Overview
4.4 Ample Medical Inc Company Overview
4.4.1 Ample Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
4.5 Ancora Heart Inc Company Overview
4.5.1 Ancora Heart Inc Pipeline Products & Ongoing Clinical Trials Overview
4.6 Aporo Biomedical, Inc. (Inactive) Company Overview
4.6.1 Aporo Biomedical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
4.7 AuriGen Medical Ltd Company Overview
4.7.1 AuriGen Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
4.8 BioStable Science & Engineering, Inc. Company Overview
4.8.1 BioStable Science & Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview
4.9 BioVentrix Inc Company Overview
4.9.1 BioVentrix Inc Pipeline Products & Ongoing Clinical Trials Overview
4.10 CARAG AG Company Overview
4.10.1 CARAG AG Pipeline Products & Ongoing Clinical Trials Overview
4.11 Cardiac Dimensions Inc Company Overview
4.11.1 Cardiac Dimensions Inc Pipeline Products & Ongoing Clinical Trials Overview
4.12 Cardiosolutions Inc Company Overview
4.12.1 Cardiosolutions Inc Pipeline Products & Ongoing Clinical Trials Overview
4.13 Celyad SA Company Overview
4.13.1 Celyad SA Pipeline Products & Ongoing Clinical Trials Overview
4.14 Children's Hospital Boston Company Overview
4.14.1 Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview
4.15 Cierra, Inc. (Inactive) Company Overview
4.15.1 Cierra, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
4.16 Collplant Biotechnologies Ltd Company Overview
4.16.1 Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
4.17 coramaze technologies GmbH Company Overview
4.17.1 coramaze technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview
4.18 CoreMedic AG Company Overview
4.18.1 CoreMedic AG Pipeline Products & Ongoing Clinical Trials Overview
4.19 CUBE SRL Company Overview
4.19.1 CUBE SRL Pipeline Products & Ongoing Clinical Trials Overview
4.20 Daidalos Solutions BV Company Overview
4.20.1 Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview
5 Cardiovascular Prosthetic Devices- Recent Developments
5.1 Nov 20, 2019: FDA approves BioVentrix’s Revivent TC system
5.2 Nov 20, 2019: LivaNova to restructure its heart valve business line and End Caisson Transcatheter Mitral Valve Replacement Program
5.3 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019
5.4 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report
5.5 Nov 12, 2019: Cook Medical’s leadership updates in Asia-pacific reinforce focus on growth and physician relationships
6 Appendix
6.1 Methodology
6.2 About the Author
6.3 Contact Us
6.4 Disclaimer
List of Tables
Table 1: Cardiovascular Prosthetic Devices - Pipeline Products by Stage of Development
Table 2: Cardiovascular Prosthetic Devices - Pipeline Products by Segment
Table 3: Cardiovascular Prosthetic Devices - Pipeline Products by Territory
Table 4: Cardiovascular Prosthetic Devices - Pipeline Products by Regulatory Path
Table 5: Cardiovascular Prosthetic Devices - Pipeline Products by Estimated Approval Date
Table 6: Cardiovascular Prosthetic Devices - Ongoing Clinical Trials
Table 7: Cardiovascular Prosthetic Devices Companies - Pipeline Products by Stage of Development
Table 8: Cardiovascular Prosthetic Devices - Pipeline Products by Stage of Development
Table 9: 4Tech Cardio Ireland Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 10: TriCinch Coil Tricuspid Valve Repair System - Product Status
Table 11: TriCinch Coil Tricuspid Valve Repair System - Product Description
Table 12: 4Tech Cardio Ireland Ltd - Ongoing Clinical Trials Overview
Table 13: TriCinch Coil Tricuspid Valve Repair System - Clinical Trial Evaluation of the Percutaneous 4Tech TriCinch Coil Tricuspid Valve Repair System
Table 14: TriCinch Coil Tricuspid Valve Repair System - Early Feasibility Study of the Percutaneous 4Tech TriCinch Coil Tricuspid Valve Repair System
Table 15: TriCinch Coil Tricuspid Valve Repair System - Early Feasibility Study of TriCinch Coil Tricuspid Valve Repair System
Table 16: TriCinch Coil Tricuspid Valve Repair System - International Multisite Transcatheter Tricuspid Valve Therapies Registry
Table 17: Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 18: TriClip Device - Product Status
Table 19: TriClip Device - Product Description
Table 20: Abbott Vascular Inc - Ongoing Clinical Trials Overview
Table 21: TriClip Device - Clinical Trial to Evaluate Cardiovascular Outcomes in Patients Treated with the Tricuspid Valve Repair System Pivotal
Table 22: TriClip Device - Trial to Evaluate Treatment with Abbott Transcatheter Clip Repair System in Patients with Moderate or Greater Tricuspid Regurgitation (TRILUMINATE)
Table 23: Affluent Medical SA Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Epygon - Product Status
Table 25: Epygon - Product Description
Table 26: Kalios - Product Status
Table 27: Kalios - Product Description
Table 28: Affluent Medical SA - Ongoing Clinical Trials Overview
Table 29: Kalios - OPTIMISE II: Optimisation of Surgical Repair for Treating Insufficiency of the Mitral Valve - Safety and Effectiveness Evaluation
Table 30: Ample Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 31: PS3 System - Product Status
Table 32: PS3 System - Product Description
Table 33: Ancora Heart Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 34: AccuCinch Ventriculoplasty System - Product Status
Table 35: AccuCinch Ventriculoplasty System - Product Description
Table 36: Ancora Heart Inc - Ongoing Clinical Trials Overview
Table 37: AccuCinch Ventriculoplasty System - A Study of Percutaneous Repair of Functional Mitral Regurgitation Using the Ancora Heart, Inc. AccuCinch Ventricular Repair System - The CINCH-2 Study
Table 38: AccuCinch Ventriculoplasty System - An Early Feasibility Evaluation of the AccuCinch Ventricular Repair System in Patients with Heart Failure and Reduced Ejection Fraction (HFrEF) - The CorCinch-HFrEF Study
Table 39: AccuCinch Ventriculoplasty System - An Early Feasibility Study of the AccuCinch Ventricular Repair System in Patients with Prior Mitral Valve Intervention (PMVI) and Recurrent Mitral Regurgitation - The CorCinch-PMVI Study
Table 40: AccuCinch Ventriculoplasty System - Early Feasibility Study of the AccuCinch Ventricular Repair System
Table 41: AccuCinch Ventriculoplasty System - Safety and Performance Evaluation of the AccuCinch Ventricular Repair System for Functional Mitral Regurgitation Due to Dilated Ischemic or Non-Ischemic Cardiomyopathy - The CorCinch-EU Study
Table 42: Aporo Biomedical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 43: Patent Foramen Ovale Closure Device - Product Status
Table 44: Patent Foramen Ovale Closure Device - Product Description
Table 45: AuriGen Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 46: Trans-Septal Implant - Product Status
Table 47: Trans-Septal Implant - Product Description
Table 48: BioStable Science & Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 49: HAART 200 Aortic Annuloplasty Device - Product Status
Table 50: HAART 200 Aortic Annuloplasty Device - Product Description
Table 51: BioStable Science & Engineering, Inc. - Ongoing Clinical Trials Overview
Table 52: HAART 200 Aortic Annuloplasty Device - Safety and Performance of Aortic Valve Repair Using the HAART Aortic Annuloplasty Devices - A Registry Study
Table 53: BioVentrix Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 54: Revivent-TC System - Product Status
Table 55: Revivent-TC System - Product Description
Table 56: BioVentrix Inc - Ongoing Clinical Trials Overview
Table 57: Revivent-TC System - Clinical Study of the BioVentrix Revivent TC for the Treatment of Ischemic Cardiomyopathy
Table 58: Revivent-TC System - Clinical Study of the BioVentrix Revivent TC System for Treatment of Left Ventricular Aneurysms (ALIVE)
Table 59: Revivent-TC System - Phase II Study of the BioVentrix PliCath HF System for the Treatment of Ischemic Cardiomyopathy
Table 60: Revivent-TC System - Randomized Evaluation and Verification of Ventricular Enhancement: The REVIVE-HF Study
Table 61: CARAG AG Pipeline Products & Ongoing Clinical Trials Overview
Table 62: Carag BioResorbable Septal Occluder - Product Status
Table 63: Carag BioResorbable Septal Occluder - Product Description
Table 64: CARAG AG - Ongoing Clinical Trials Overview
Table 65: Carag BioResorbable Septal Occluder - Multi Centre, International, Post Market Registry to Monitor the Clinical Performance and Safety of an Atrial Septal Closure Device with Bioresorbable Framework in Patients with Clinically Significant Atrial Septum Defect (ASD) or Patent Foramen Ovale (PFO) in Routine Clinical Use
Table 66: Cardiac Dimensions Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 67: CARILLON Mitral Contour System - Product Status
Table 68: CARILLON Mitral Contour System - Product Description
Table 69: Cardiac Dimensions Inc - Ongoing Clinical Trials Overview
List of Figures
Figure 1: Cardiovascular Prosthetic Devices - Pipeline Products by Stage of Development
Figure 2: Cardiovascular Prosthetic Devices - Pipeline Products by Segment
Figure 3: Cardiovascular Prosthetic Devices - Pipeline Products by Territory
Figure 4: Cardiovascular Prosthetic Devices - Pipeline Products by Regulatory Path
Figure 5: Cardiovascular Prosthetic Devices - Pipeline Products by Estimated Approval Date
Figure 6: Cardiovascular Prosthetic Devices - Ongoing Clinical Trials

Companies Mentioned

A selection of companies mentioned in this report includes:

  • 4Tech Cardio Ireland Ltd
  • Abbott Vascular Inc
  • Affluent Medical SA
  • Ample Medical Inc
  • Ancora Heart Inc
  • AuriGen Medical Ltd
  • BioStable Science & Engineering, Inc.
  • BioVentrix Inc
  • CARAG AG
  • Cardiac Dimensions Inc
  • Cardiosolutions Inc
  • Celyad SA
  • Children's Hospital Boston
  • Collplant Biotechnologies Ltd
  • coramaze technologies GmbH
  • CoreMedic AG
  • CUBE SRL
  • Daidalos Solutions BV
  • Dextera Surgical Inc
  • Edwards Lifesciences Corp
  • Emory University
  • Ension, Inc.
  • Georgia Institute of Technology
  • Hangzhou DeJin Medtech Co Ltd
  • InnovHeart SRL
  • IPI Singapore
  • Kardium Inc
  • Lifetech Scientific (Shenzhen) Co Ltd
  • Mardil Medical, Inc.
  • Mayo Clinic
  • Medtentia International Ltd Oy
  • MiCardia Corp
  • Michigan Critical Care Consultants, Inc.
  • Micro Interventional Devices, Inc.
  • Millipede LLC
  • Mitral Heal
  • Mitralign Inc
  • Mitralix Ltd.
  • Mitre Medical Corp
  • MVRx, Inc.
  • Neochord Inc
  • North Carolina State University
  • Occlufit AG
  • Occlutech International AB
  • Phoenix Cardiac Devices, Inc.
  • Pipeline Medical Technologies Inc
  • Rambam Health Care Campus
  • ReCor Medical Inc
  • SCR, Inc.
  • St. Jude Medical LLC
  • Strait Access Technologies (Pty) Ltd
  • Symetis SA
  • Tel Aviv Sourasky Medical Center
  • TransCardiac Therapeutics, LLC
  • Transmural systems LLC
  • TTK Healthcare Ltd
  • University of Manitoba
  • University of Minnesota
  • University of South Carolina
  • Valcare Medical
  • valsculp
  • Valtech Cardio Ltd
  • Vanderbilt University
  • Vascular Concepts Ltd
  • Viacor Inc
  • W. L. Gore & Associates Inc
  • Xeltis AG

Related Topics

Related Reports

Cardiovascular Prosthetic Devices Market by Type, End-user: Global Opportunity Analysis and Industry Forecast, 2021-2031 - Product Image

Cardiovascular Prosthetic Devices Market by Type, End-user: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • Report
  • 248 Pages
  • Global
From
The Global Market for Medical Devices, 13th Edition - Product Image

The Global Market for Medical Devices, 13th Edition

  • Report
  • 312 Pages
  • Global
From
Cardiovascular Devices Market Report 2023-2033 - Product Image

Cardiovascular Devices Market Report 2023-2033

  • Report
  • 273 Pages
  • Global
From
Cardiovascular Prosthetic Device Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Cardiovascular Prosthetic Device Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 96 Pages
  • Global
From
Surgical Heart Valves Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update - Product Image

Surgical Heart Valves Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

  • Report
  • 348 Pages
  • Global
From
Copyright © 2002-2023 Research and Markets. All Rights Reserved.